Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
British Journal of Haematology
|
October 1, 2010
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
Véronique Gelsi-Boyer, Virginie Trouplin, Julien Roquain, et al.
Genes, Chromosomes & Cancer
|
June 12, 2003
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene
José Adélaïde, Huai-En Huang, Anne Murati, et al.
Acta Haematologica
|
June 15, 2026
Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study
Edmond Chiche, Caroline Fileni, Sarah Bonnet, et al.
American Journal of Hematology
|
May 29, 2015
Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis
Charles Herbaux, Nicolas Duployez, Catherine Badens, et al.
European Journal of Haematology
|
August 12, 2024
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics
Amel Soua, Julia Gilhodes, Alexandre Iat, et al.
British Journal of Haematology
|
November 12, 2019
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
Laurane Cottin, Jérémie Riou, Corentin Orvain, et al.
Blood Advances
|
October 9, 2020
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
Damien Luque Paz, Rébecca Jouanneau-Courville, Jérémie Riou, et al.
American Journal of Hematology
|
February 26, 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM
Laura Aubin, Rúben Vilas Boas, Rafael Daltro De Oliveira, et al.
Blood Advances
|
March 5, 2021
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
Damien Luque Paz, Jérémie Riou, Emmanuelle Verger, et al.
Leukemia
|
April 1, 2025
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study
Lucile Bussot, Stéphanie Poulain, Morgane Nudel Ortmans, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
British Journal of Haematology
|
October 1, 2010
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
Véronique Gelsi-Boyer, Virginie Trouplin, Julien Roquain, et al.
Genes, Chromosomes & Cancer
|
June 12, 2003
A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene
José Adélaïde, Huai-En Huang, Anne Murati, et al.
Acta Haematologica
|
June 15, 2026
Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study
Edmond Chiche, Caroline Fileni, Sarah Bonnet, et al.
American Journal of Hematology
|
May 29, 2015
Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis
Charles Herbaux, Nicolas Duployez, Catherine Badens, et al.
European Journal of Haematology
|
August 12, 2024
Venetoclax-based non-intensive induction followed by allogenic stem-cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics
Amel Soua, Julia Gilhodes, Alexandre Iat, et al.
British Journal of Haematology
|
November 12, 2019
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
Laurane Cottin, Jérémie Riou, Corentin Orvain, et al.
Blood Advances
|
October 9, 2020
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
Damien Luque Paz, Rébecca Jouanneau-Courville, Jérémie Riou, et al.
American Journal of Hematology
|
February 26, 2024
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM
Laura Aubin, Rúben Vilas Boas, Rafael Daltro De Oliveira, et al.
Blood Advances
|
March 5, 2021
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
Damien Luque Paz, Jérémie Riou, Emmanuelle Verger, et al.
Leukemia
|
April 1, 2025
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study
Lucile Bussot, Stéphanie Poulain, Morgane Nudel Ortmans, et al.
Page
of 4